Open Access | Research Article Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy
Authors: Dayna Jill Isaacs, Nikhita Kathuria-Prakash, Robin Hilder, et al. Journal: Current Cancer Reports DOI:10.25082/CCR.2023.01.004 Pub. Date: January 29, 2024
